BIOA Competitors & Alternatives

Compare BioAge Labs, Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

BIOA

Main Stock
$22.83
Tradestie Score
57
Market Cap
$212.23M
Revenue Growth
0.9%
Analyst Upside
+116.8%

Top Competitors

47 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
XERS Xeris Biopharma Holdings, Inc. Common Stock
$7.40
$1.29B 98.6 67 Compare
AMPH Amphastar Pharmaceuticals, Inc.
$21.02
$1.25B 11.0 58 Compare
DVAX Dynavax Technologies Corporation
$15.50
$1.21B - 55 Compare
PCRX Pacira BioSciences, Inc. Common Stock
$23.96
$1.14B 174.7 64 Compare
COLL Collegium Pharmaceutical, Inc. Common Stock
$35.58
$1.11B 16.7 61 Compare
CRON Cronos Group Inc. Common Share
$2.71
$1.02B - 55 Compare
ZBIO Zenas BioPharma, Inc. Common Stock
$21.80
$931.48M - 66 Compare
BCAX Bicara Therapeutics Inc. Common Stock
$25.64
$906.29M - 55 Compare
MBX MBX Biosciences, Inc. Common Stock
$48.40
$800.41M - 52 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.99
$711.32M - 63 Compare

Data updated: Jun 24, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

47 stocks in this industry